Nuclear Medicine Communications

Papers
(The H4-Index of Nuclear Medicine Communications is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Simulated daily readout for maintaining nuclear medicine education in residency training amidst declining case volume: evidence from the COVID-19 pandemic31
[18F]-PSMA-1007 PET imaging optimization and inter-rater reliability – a comparison of three different reconstructions read by four radiologists24
Is a strict restricted-iodine diet necessary for preparation of radioactive iodine therapy?22
Comparison of the role of 18F-fluorodeoxyglucose PET/computed tomography and 68Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma21
Metabolic parameters on [18F]fluoro-2-deoxy-d-glucose PET/MRI: feasibility study comparing standardized uptake value quantification obtained from dedicated breast and whole-body scans within a single 21
PET/computed tomography radiomics combined with clinical features in predicting sarcopenia and prognosis of diffuse large B-cell lymphoma20
Associations between brown adipose tissue activity, serum lipid profiles, and cardiovascular events: insights from 18F-fluorodeoxyglucose PET/computed tomography analysis16
Comparison of 68Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies16
Impact of acquisition timing and background uptake on [131I]meta-iodobenzylguanidine SPECT/CT interpretation in pheochromocytoma and adrenal adenoma16
Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma15
Semiquantitative analysis of 18F-aluminum fluoride fibroblast activation protein inhibitor 42 PET/computed tomography in primary liver cancer and factors influencing imaging positivity rates14
Application of 18F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy13
Feasibility of real-time monitoring for administered activity during Lu-177 infusion by imaging the administration site using a pinhole gamma camera: a Monte Carlo study13
0.43943190574646